The Deal

Activist Investing Today: Eldar on Anti-Activist Pill Evolution

The Deal

When corporations install anti-activist poison pills they are less likely to implement new share buybacks and their operationally-focused capital expenditures tend to be higher, UC Berkeley School of Law professor Ofer Eldar explains.